EGFR and non-small cell lung carcinoma: This interest is derived from recent work where we measured the frequency-dependent ecological interaction between an evolved epidermal growth factor (EGFR) tyrosine kinase inhibitor (TKI) resistant non-small-cell lung cancer (NSCLC) population and its TKI-sensitive ancestor [40].